XML 47 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Segment and Geographical Information (Tables)
 12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
(In millions)
 
2018

 
2017

 
2016

 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
Life Sciences Solutions
 
$
6,269

 
$
5,728

 
$
5,317

Analytical Instruments
 
5,469

 
4,821

 
3,668

Specialty Diagnostics
 
3,724

 
3,486

 
3,339

Laboratory Products and Services
 
10,035

 
7,825

 
6,724

Eliminations
 
(1,139
)
 
(942
)
 
(774
)
 
 
 
 
 
 
 
Consolidated revenues
 
24,358

 
20,918

 
18,274

 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
Life Sciences Solutions
 
2,158

 
1,894

 
1,598

Analytical Instruments
 
1,247

 
1,027

 
749

Specialty Diagnostics
 
952

 
927

 
910

Laboratory Products and Services
 
1,258

 
1,004

 
974

 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
5,615

 
4,852

 
4,231

 
 
 
 
 
 
 
Cost of revenues charges, net
 
(12
)
 
(123
)
 
(102
)
Selling, general and administrative charges, net
 
(29
)
 
(78
)
 
(104
)
Restructuring and other costs, net
 
(50
)
 
(97
)
 
(189
)
Amortization of acquisition-related intangible assets
 
(1,741
)
 
(1,594
)
 
(1,378
)
 
 
 
 
 
 
 
Consolidated operating income
 
3,783

 
2,960

 
2,458

Other expense, net (b)
 
(521
)
 
(531
)
 
(434
)
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
3,262

 
$
2,429

 
$
2,024

 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
Life Sciences Solutions
 
$
119

 
$
129

 
$
142

Analytical Instruments
 
73

 
71

 
50

Specialty Diagnostics
 
76

 
72

 
70

Laboratory Products and Services
 
258

 
167

 
118

 
 
 
 
 
 
 
Consolidated depreciation
 
$
526

 
$
439

 
$
380

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
(In millions)
 
2018

 
2017

 
2016

 
 
 
 
 
 
 
Total Assets
 
 
 
 
 
 
Life Sciences Solutions
 
$
18,774

 
$
19,063

 
$
19,065

Analytical Instruments
 
9,907

 
9,960

 
9,520

Specialty Diagnostics
 
6,663

 
7,095

 
6,802

Laboratory Products and Services
 
19,051

 
19,181

 
9,405

Corporate/Other (c)
 
1,837

 
1,370

 
1,116

 
 
 
 
 
 
 
Consolidated total assets
 
$
56,232

 
$
56,669

 
$
45,908

 
 
 
 
 
 
 
Capital Expenditures
 
 
 
 
 
 
Life Sciences Solutions
 
$
107

 
$
118

 
$
122

Analytical Instruments
 
85

 
56

 
34

Specialty Diagnostics
 
103

 
87

 
72

Laboratory Products and Services
 
374

 
178

 
111

Corporate/Other
 
89

 
69

 
105

 
 
 
 
 
 
 
Consolidated capital expenditures
 
$
758

 
$
508

 
$
444

(c)
Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
(In millions)
 
2018

 
2017

 
2016

 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
Life Sciences Solutions
 
$
6,269

 
$
5,728

 
$
5,317

Analytical Instruments
 
5,469

 
4,821

 
3,668

Specialty Diagnostics
 
3,724

 
3,486

 
3,339

Laboratory Products and Services
 
10,035

 
7,825

 
6,724

Eliminations
 
(1,139
)
 
(942
)
 
(774
)
 
 
 
 
 
 
 
Consolidated revenues
 
24,358

 
20,918

 
18,274

 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
Life Sciences Solutions
 
2,158

 
1,894

 
1,598

Analytical Instruments
 
1,247

 
1,027

 
749

Specialty Diagnostics
 
952

 
927

 
910

Laboratory Products and Services
 
1,258

 
1,004

 
974

 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
5,615

 
4,852

 
4,231

 
 
 
 
 
 
 
Cost of revenues charges, net
 
(12
)
 
(123
)
 
(102
)
Selling, general and administrative charges, net
 
(29
)
 
(78
)
 
(104
)
Restructuring and other costs, net
 
(50
)
 
(97
)
 
(189
)
Amortization of acquisition-related intangible assets
 
(1,741
)
 
(1,594
)
 
(1,378
)
 
 
 
 
 
 
 
Consolidated operating income
 
3,783

 
2,960

 
2,458

Other expense, net (b)
 
(521
)
 
(531
)
 
(434
)
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
3,262

 
$
2,429

 
$
2,024

 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
Life Sciences Solutions
 
$
119

 
$
129

 
$
142

Analytical Instruments
 
73

 
71

 
50

Specialty Diagnostics
 
76

 
72

 
70

Laboratory Products and Services
 
258

 
167

 
118

 
 
 
 
 
 
 
Consolidated depreciation
 
$
526

 
$
439

 
$
380

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Geographical Information
(In millions)
 
2018

 
2017

 
2016

 
 
 
 
 
 
 
Revenues (d)
 
 
 
 
 
 
United States
 
$
11,629

 
$
10,129

 
$
9,086

China
 
2,504

 
2,060

 
1,730

Other
 
10,225

 
8,729

 
7,458

 
 
 
 
 
 
 
Consolidated revenues
 
$
24,358

 
$
20,918

 
$
18,274

 
 
 
 
 
 
 
Long-lived Assets (e)
 
 
 
 
 
 
United States
 
$
2,444

 
$
2,349

 
$
1,630

Other
 
1,721

 
1,698

 
948

 
 
 
 
 
 
 
Consolidated long-lived assets
 
$
4,165

 
$
4,047

 
$
2,578

(d)
Revenues are attributed to countries based on customer location.
(e)
Includes property, plant and equipment, net